A Phase 1/1b, Open Label, Dose Escalation and Expansion Study of SBT6050 in Patients with Advanced Solid Tumors Expressing HER2
- Sabanathan, Dhanusha, (Primary Chief Investigator)
- Park, John (Associate Investigator)
- Chapman, Nicola, (Clinical Trial Unit Staff)
Project: Research